Literature DB >> 21196372

Periacinar retraction artifact of the prostate.

Bozo Kruslin1, Davor Tomas, Gregor Mikuz.   

Abstract

Retraction artifacts are well known phenomenon in diagnostic surgical pathology for a long time but they were usually considered as artificially produced tissue alteration. Some recent studies of retraction artifact in different tumors have focused on its diagnostic and/or prognostic role. Their presence in prostatic carcinoma may be used in diagnostic and prognostic purposes. Peritumoral retraction artefacts in prostatic carcinoma are more pronounced and more common around neoplastic glands compared to benign glands, gland with prostatic intraepithelial neoplasia and postatrophic hyperplasia that is the one of the most common mimickers of prostatic carcinoma. In addition, the presence of extensive retraction artifact in prostatic carcinomas is clearly associated with tumor features that indicate a more aggressive tumor phenotype and with shorter biochemical recurrence-free survival. Studies at the molecular level demonstrate that retraction artifact may be attributed to molecules produced by reactive cancer stroma. The origin of retraction artifact in tumor specimens is unknown but they are probably the consequence of lack of basal cells and /or stromal changes but not simply artifacts due to laboratory procedures.

Entities:  

Mesh:

Year:  2011        PMID: 21196372     DOI: 10.2741/s147

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  3 in total

1.  Peritumoral Clefting and Expression of MMP-2 and MMP-9 in Basal Cell Carcinoma of the Skin.

Authors:  Ivana Manola; Ana Mataic; Daniela Ledic Drvar; Ivan Pezelj; Tihana Regovic Dzombeta; Bozo Kruslin
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Periacinar retraction clefting and d2-40 expression in prostatic adenocarcinoma.

Authors:  Monika Ulamec; Tihana Džombeta; Hrvoje Cupić; Tanja Leniček; Davor Tomas; Božo Krušlin
Journal:  Pathol Oncol Res       Date:  2011-09-13       Impact factor: 3.201

3.  Potential key roles of tumour budding: a representative malignant pathological feature of non-small cell lung cancer and a sensitive indicator of prognosis.

Authors:  Li Qian; Jianguo Zhang; Shumin Lu; Xin He; Jia Feng; Jiahai Shi; Yifei Liu
Journal:  BMJ Open       Date:  2022-03-31       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.